NO20072499L - Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser - Google Patents

Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Info

Publication number: NO20072499L
Authority: NO; Norway
Prior art keywords: methods; receptor binding; compositions; applications; melanocortin receptor
Prior art date: 2004-10-25

Application number

NO20072499A

Other languages

English (en)

Norwegian (no)

Inventor

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Chichi Huang

Jeffrey Luo

Original Assignee

Centocor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2007-05-15

Publication date

2007-07-16

2007-05-15 Application filed by Centocor Inc filed Critical Centocor Inc

2007-07-16 Publication of NO20072499L publication Critical patent/NO20072499L/no

Links

102000004378 Melanocortin Receptors Human genes 0.000 title abstract 2
108090000950 Melanocortin Receptors Proteins 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
239000000126 substance Substances 0.000 title 1
102000040430 polynucleotide Human genes 0.000 abstract 2
108091033319 polynucleotide Proteins 0.000 abstract 2
239000002157 polynucleotide Substances 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Hematology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO20072499A 2004-10-25 2007-05-15 Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser NO20072499L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25
PCT/US2005/038431 WO2006047535A2 (en)	2004-10-25	2005-10-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number	Publication Date
NO20072499L true NO20072499L (no)	2007-07-16

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20072499A NO20072499L (no)	2004-10-25	2007-05-15	Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Country Status (28)

Country	Link
US (1)	US20060105951A1 (pl)
EP (1)	EP1812046B1 (pl)
JP (1)	JP2008517605A (pl)
KR (1)	KR101255140B1 (pl)
CN (1)	CN101437540B (pl)
AT (1)	ATE501731T1 (pl)
AU (1)	AU2005299440B2 (pl)
BR (1)	BRPI0518411A2 (pl)
CA (1)	CA2585287A1 (pl)
CY (1)	CY1111486T1 (pl)
DE (1)	DE602005026970D1 (pl)
DK (1)	DK1812046T3 (pl)
EA (1)	EA200700944A1 (pl)
EC (1)	ECSP077416A (pl)
ES (1)	ES2363023T3 (pl)
HR (1)	HRP20110405T1 (pl)
IL (1)	IL182683A0 (pl)
MA (1)	MA28943B1 (pl)
ME (1)	ME01234B (pl)
MX (1)	MX2007004974A (pl)
NO (1)	NO20072499L (pl)
PL (1)	PL1812046T3 (pl)
PT (1)	PT1812046E (pl)
RS (1)	RS51789B (pl)
SI (1)	SI1812046T1 (pl)
TN (1)	TNSN07157A1 (pl)
WO (1)	WO2006047535A2 (pl)
ZA (1)	ZA200704260B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en)	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) *	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
WO2009151383A1 (en) *	2008-06-09	2009-12-17	Palatin Technologies, Inc.	Melanocortin receptor-specific peptides for the treatment of obesity and other diseases associated with melanocortin receptor function
KR101687037B1 (ko)	2008-06-09	2016-12-15	팔라틴 테크놀로지스 인코포레이티드	성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
EP2440572B1 (en)	2009-06-08	2017-04-05	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
CA2761607C (en)	2009-06-08	2018-09-04	Yi-Qun Shi	Melanocortin receptor-specific peptides
BR112012011780A2 (pt)	2009-11-23	2019-09-24	Palatin Technologies, Inc	peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP5999702B2 (ja)	2009-11-23	2016-09-28	パラティンテクノロジーズ, インコーポレイテッドPalatin Technologies, Inc.	メラノコルチン−１受容体特異的環状ペプチド
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) *	2019-03-02	2020-09-10	上海一宸医药科技有限公司	一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1137340A4 (en) *	1998-12-09	2005-12-21	Eleanor Roosevelt Inst	COMPOSITION AND METHODS FOR REGULATION OF BODY WEIGHT AND ASSOCIATED PATHOLOGIES
AU7593001A (en) *	2000-07-14	2002-01-30	Zycos Inc	Alpha-msh related compounds and methods of use
CA2490409A1 (en) *	2002-06-28	2004-01-08	Centocor, Inc.	Mammalian ch1 deleted mimetibodies, compositions, methods and uses
US7241733B2 (en) *	2002-06-28	2007-07-10	Centocor, Inc.	Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
US20070135338A1 (en) *	2004-03-31	2007-06-14	Karyn O'neil	Human GLP-1 mimetibodies, compositions, methods and uses

2005
- 2005-10-25 RS RS20110230A patent/RS51789B/sr unknown
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 HR HR20110405T patent/HRP20110405T1/hr unknown
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active Expired - Fee Related
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/me unknown
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/en not_active Ceased
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de not_active Expired - Lifetime
- 2005-10-25 EP EP05819741A patent/EP1812046B1/en not_active Expired - Lifetime
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es not_active Expired - Lifetime
- 2005-10-25 CA CA002585287A patent/CA2585287A1/en not_active Abandoned
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown

Also Published As

Publication number	Publication date
AU2005299440A1 (en)	2006-05-04
DK1812046T3 (da)	2011-06-06
US20060105951A1 (en)	2006-05-18
EP1812046A4 (en)	2009-11-11
ME01234B (me)	2013-06-20
EP1812046B1 (en)	2011-03-16
ATE501731T1 (de)	2011-04-15
EP1812046A2 (en)	2007-08-01
HK1106445A1 (en)	2008-03-14
RS51789B (sr)	2011-12-31
MX2007004974A (es)	2007-10-17
DE602005026970D1 (de)	2011-04-28
MA28943B1 (fr)	2007-10-01
ZA200704260B (en)	2009-03-25
ES2363023T3 (es)	2011-07-19
IL182683A0 (en)	2007-09-20
CA2585287A1 (en)	2006-05-04
PT1812046E (pt)	2011-06-28
HRP20110405T1 (hr)	2011-06-30
KR20070085416A (ko)	2007-08-27
ECSP077416A (es)	2007-05-30
WO2006047535A2 (en)	2006-05-04
CN101437540A (zh)	2009-05-20
AU2005299440B2 (en)	2011-12-15
PL1812046T3 (pl)	2011-08-31
KR101255140B1 (ko)	2013-04-22
EA200700944A1 (ru)	2008-04-28
BRPI0518411A2 (pt)	2008-11-18
WO2006047535A3 (en)	2008-09-04
JP2008517605A (ja)	2008-05-29
CY1111486T1 (el)	2015-08-05
TNSN07157A1 (en)	2008-11-21
SI1812046T1 (sl)	2011-06-30
CN101437540B (zh)	2012-12-19

Legal Events

Date	Code	Title	Description
2018-05-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20072499L (no)	2007-07-16	Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser
WO2007041635A3 (en)	2008-11-13	Fc variants with optimized fc receptor binding properties
TW200611910A (en)	2006-04-16	Interferon-alpha polypeptides and conjugates
WO2006083276A3 (en)	2009-04-16	Interferon-alpha polypeptides and conjugates
DK1864132T3 (da)	2012-07-16	Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
DK2574640T3 (da)	2023-04-24	Bindemidler og dermed fremstillede materialer
DK2390267T3 (da)	2013-08-26	Stabile og opløselige antistoffer, der hæmmer TNF(alfa)
WO2006017538A3 (en)	2007-05-18	Hk1-binding proteins
WO2006055689A3 (en)	2009-04-09	Protein scaffolds and uses thereof
GB0700909D0 (en)	2007-02-28	Novel antigen-binding polypeptides and their uses
DK1919514T3 (da)	2012-08-20	Polynucleotider kodende for isoprenoid-modificerende enzymer og fremgangsmåder til anvendelse deraf
DK1871805T3 (da)	2019-12-02	Antigenbindende molekyler der binder egfr, vektorer der koder derfor, og anvendelser deraf
EP1940217A4 (en)	2009-11-11	ISOLATED POLYPEPTIDES, POLYNUCLEOTIDES ENCODING THESE, TRANSGENIC PLANTS EXPRESSING THESE AND METHODS USING SAME
WO2007104062A3 (en)	2008-11-27	Compositions and methods based on peptide binding profiling
NO20082240L (no)	2008-07-22	GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
WO2007079218A3 (en)	2008-07-10	Metalloproteinase binding proteins
NO20083397L (no)	2008-10-02	Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
NO20055686L (no)	2007-06-04	Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
BRPI0613770A2 (pt)	2009-05-19	anticorpos anti-cd26 e métodos de uso destes
NO20091181L (no)	2009-05-18	Anti-C5AR-antistoffer med forbedrede egenskaper
WO2008154547A3 (en)	2009-02-26	Spider silk dragline polynucleotides, polypeptides and methods of use thereof
TW200745159A (en)	2007-12-16	IL-6 binding proteins
DK1844072T3 (da)	2012-07-23	MHC-oligomer og fremgangsmåde til fremstilling deraf
WO2007044083A3 (en)	2009-04-16	Evolved interferon-alpha polypeptides
MX296535B (es)	2012-02-29	Enzima laccasa novedosa y uso de la misma.